|
|
Volumn 355, Issue 13, 2006, Pages 1386-1387
|
|
Treatment of gastric cancer [3]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CANCER STAGING;
CANCER SURGERY;
CONFIDENCE INTERVAL;
ESOPHAGUS TUMOR;
HUMAN;
LETTER;
PERIOPERATIVE PERIOD;
PRIORITY JOURNAL;
STOMACH CANCER;
TUMOR VOLUME;
ADJUVANT CHEMOTHERAPY;
EPIDEMIOLOGY;
LOWER ESOPHAGUS SPHINCTER;
NOTE;
PATHOLOGY;
STOMACH TUMOR;
LYMPH NODE METASTASIS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIAS (EPIDEMIOLOGY);
CHEMOTHERAPY, ADJUVANT;
CONFIDENCE INTERVALS;
ESOPHAGEAL NEOPLASMS;
ESOPHAGOGASTRIC JUNCTION;
HUMANS;
NEOPLASM STAGING;
STOMACH NEOPLASMS;
LYMPHATIC METASTASIS;
|
|
EID: 33749050438
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc062091 Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|
